Varex Imaging Corp (VREX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Varex Imaging Corp stock (VREX) is currently trading at $10.62. Varex Imaging Corp PS ratio (Price-to-Sales) is 0.52. Analyst consensus price target for VREX is $18.40. WallStSmart rates VREX as Underperform.
- VREX PE ratio analysis and historical PE chart
- VREX PS ratio (Price-to-Sales) history and trend
- VREX intrinsic value — DCF, Graham Number, EPV models
- VREX stock price prediction 2025 2026 2027 2028 2029 2030
- VREX fair value vs current price
- VREX insider transactions and insider buying
- Is VREX undervalued or overvalued?
- Varex Imaging Corp financial analysis — revenue, earnings, cash flow
- VREX Piotroski F-Score and Altman Z-Score
- VREX analyst price target and Smart Rating
Varex Imaging Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Varex Imaging Corp (VREX) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Concerns around peg ratio and return on equity. Fundamentals are solid but monitor weak areas for improvement.
Varex Imaging Corp (VREX) Key Strengths (4)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Earnings per share surging 453.40% year-over-year
98.75% of shares held by major funds and institutions
Supporting Valuation Data
Varex Imaging Corp (VREX) Areas to Watch (6)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Very expensive relative to growth, significant premium
Very thin margins with limited operational efficiency
Revenue growing slowly at 4.90% annually
Small-cap company with higher risk but more growth potential
Varex Imaging Corp (VREX) Detailed Analysis Report
Overall Assessment
This company scores 52/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, EPS Growth. Valuation metrics including Price/Sales (0.52), Price/Book (0.94) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 453.40%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, PEG Ratio. Some valuation metrics including PEG Ratio (6.30) suggest expensive pricing. Growth concerns include Revenue Growth at 4.90%, which may limit upside. Profitability pressure is visible in Return on Equity at -12.90%, Operating Margin at 7.35%, Profit Margin at -7.92%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -12.90% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 4.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Price/Book) and negatives (Return on Equity, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
VREX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
VREX's Price-to-Sales ratio of 0.52x trades at a deep discount to its historical average of 1.23x (3th percentile). The current valuation is 80% below its historical high of 2.6x set in Jan 2018, and 30% above its historical low of 0.4x in May 2025. Over the past 12 months, the PS ratio has compressed from ~0.6x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Varex Imaging Corp (VREX) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Varex Imaging Corp is in a turnaround phase, with management focused on restoring profitability. Revenue reached 854M with 5% growth year-over-year. The company is currently unprofitable, posting a -7.9% profit margin.
Key Findings
Debt-to-equity ratio of 0.06 indicates a conservative balance sheet with 120M in cash.
The company is unprofitable with a -7.9% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -27M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Varex Imaging Corp.
Bottom Line
Varex Imaging Corp is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Varex Imaging Corp(VREX)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company is headquartered in Salt Lake City, Utah.